Bacil Pharma Limited (BOM:524516)

Bacil Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	28.57	0.41	0.29	2.3	0.99
Trading Asset Securities	-	-	1.91	0.76	1.39
Cash & Short-Term Investments	28.57	0.41	2.2	3.06	2.38
Cash Growth	6788.38%	-81.12%	-28.26%	28.71%	7.33%
Other Receivables	-	-	-	-	0
Receivables	-	-	-	-	0
Other Current Assets	0.5	0.11	0.09	0.1	0.64
Total Current Assets	29.08	0.52	2.29	3.16	3.02
Property, Plant & Equipment	-	0.06	0.08	0.11	0.15
Long-Term Investments	213.57	6.11	2.36	2.36	2.36
Long-Term Deferred Tax Assets	0.54	0.56	1.17	1.08	1.08
Other Long-Term Assets	-0	-	0	-0	25
Total Assets	256	13.26	11.27	12.72	40.88
Accounts Payable	0.05	0.04	0	0.11	0.11
Accrued Expenses	-	0.09	0.06	0.02	0.09
Short-Term Debt	1.64	0.98	0.21	0.33	1.76
Current Unearned Revenue	-	-	-	-	25
Other Current Liabilities	-	0.02	0.01	0.02	0.01
Total Current Liabilities	1.69	1.13	0.28	0.47	26.97
Other Long-Term Liabilities	-	-	0	-	-
Total Liabilities	1.69	1.13	0.28	0.47	26.97
Common Stock	139.7	58.9	58.9	58.9	58.9
Retained Earnings	114.61	-53.14	-54.28	-53.03	-51.36
Comprehensive Income & Other	-0	6.37	6.37	6.37	6.37
Shareholders' Equity	254.31	12.13	10.99	12.24	13.91
Total Liabilities & Equity	256	13.26	11.27	12.72	40.88
Total Debt	1.64	0.98	0.21	0.33	1.76
Net Cash (Debt)	26.93	-0.57	1.99	2.73	0.62
Net Cash Growth	-	-	-27.11%	338.69%	17.88%
Net Cash Per Share	4.60	-0.10	0.33	0.46	0.11
Filing Date Shares Outstanding	7.8	5.89	5.89	5.89	5.89
Total Common Shares Outstanding	7.8	5.89	5.89	5.89	5.89
Working Capital	27.39	-0.61	2.01	2.69	-23.95
Book Value Per Share	32.60	2.06	1.87	2.08	2.36
Tangible Book Value	254.31	12.13	10.99	12.24	13.91
Tangible Book Value Per Share	32.60	2.06	1.87	2.08	2.36
Machinery	-	0.55	0.59	0.59	0.59

Source: S&P Global Market Intelligence. Standard template. Financial Sources.